{"filings":[{"id":1194796,"accession_number":"0001628280-26-044620","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-06-22T20:06:22+00:00","items":["8.01"],"status":"ready","headline":"SkinHealth Systems agrees to $18M securities class action settlement; insurer pays $15M","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Company will pay $3M of $18M total; remaining $15M from insurers to settle Alghazwi v. The Beauty Health Company.","Settlement covers class period May 10, 2022 – Nov 13, 2023; no admission of wrongdoing by company or individual defendants.","Plaintiff attorneys' fees estimated at up to 30% of settlement ($5.4M) subject to court approval.","Cash payment to be escrowed within 30 days after court grants preliminary approval; settlement fully resolves class action."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1083876,"accession_number":"0001628280-26-043539","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-06-16T20:08:55+00:00","items":["5.07"],"status":"ready","headline":"SkinHealth Systems stockholders elect nine directors, ratify Deloitte, approve executive compensation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Quorum of 72.08% (93.4M of 129.6M shares) present at June 10 annual meeting.","All nine director nominees elected; votes for ranged from 56.6M (Brian Miller) to 71.3M (Sachin Shridharani).","Ratification of Deloitte as auditor approved with 93.1M votes for, 235,673 against.","Advisory say-on-pay approved: 58.6M for, 12.3M against, 1.0M abstentions.","Broker non-votes of 21.4M shares on director elections and say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":583198,"accession_number":"0001628280-26-037340","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K/A","filed_at":"2026-05-21T20:40:52+00:00","items":["5.02","9.01"],"status":"ready","headline":"SkinHealth terminates CRO Ronald Menezes without cause; $463K severance granted","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Termination effective May 6, 2026; not related to financial reporting or policy disagreements.","Cash severance of $463,000 paid bi-weekly over 12 months; plus pro-rata 2026 annual bonus payable March 2027.","COBRA premium reimbursement for duration of severance; one-year non-solicitation and confidentiality covenants.","Menezes signed a release of claims and non-disparagement; $45,000 liquidated damages for breach of confidentiality.","Separation Agreement filed as Exhibit 10.1; executed May 15, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":40321,"accession_number":"0001628280-26-034101","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-05-12T20:08:38+00:00","items":["3.01"],"status":"ready","headline":"SkinHealth receives Nasdaq deficiency notice for bid price below $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on May 8, 2026; closing bid price below $1.00 for 30 consecutive business days through May 7.","Must regain compliance by Nov 4, 2026; need closing bid price ≥ $1.00 for at least 10 consecutive trading days.","May qualify for additional 180-day cure period if met other listing standards and notifies Nasdaq of cure plan.","Company evaluating options including reverse stock split to address deficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95737,"accession_number":"0001628280-26-032099","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SkinHealth Q1 revenue $64.9M, adjusted EBITDA $8.5M; cuts FY revenue outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $64.9M (-6.8% YoY); net loss improved to ($6.6M) from ($10.1M).","Adjusted EBITDA $8.5M, margin 13.1% vs 10.4% YoY; gross margin 68.5% vs 69.8%.","Delivery systems sold 746 (down 13.5% YoY); active install base grew to 36,419.","CEO Pedro Malha cited market challenges and lowered full-year revenue outlook.","Adjusted gross margin improved to 72.2% from 71.9% on cost discipline."],"consensus_eps_estimate":-0.0787,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":64910000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95736,"accession_number":"0001628280-26-031243","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SkinHealth Systems terminates CRO Ronald Menezes without cause","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ronald Menezes terminated as Chief Revenue Officer effective May 5, 2026.","Termination not related to any disagreement on financial reporting, operations, or policies.","Company plans to enter a separation agreement; no material terms determined yet.","Amendment to be filed within four business days if definitive separation agreement reached."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95735,"accession_number":"0001628280-26-026555","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["5.02","5.03","7.01","9.01"],"status":"ready","headline":"Beauty Health renames to SkinHealth Systems; appoints three new independent directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company rebranded to SkinHealth Systems Inc. effective Apr 22, 2026; ticker SKIN unchanged.","Three new independent directors appointed: Kenneth Tripp, Dr. Sachin Shridharani, E. Scott Beattie.","Board expanded to 11 members; two current directors (Gruber, Schaison) will not be nominated for reelection at 2026 annual meeting, reducing board to 9.","Bylaws amended to reflect name change and update procedural provisions (e.g., Rule 14a-19 compliance).","New name signals shift to clinically driven medical aesthetics platform; Hydrafacial remains flagship."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109024,"accession_number":"0001628280-26-017222","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q4 net loss narrows to $8.1M; adjusted EBITDA margin 18.3%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales Q4 $82.4M (down 1% YoY); full year $300.8M (down 10% YoY).","Gross margin improved to 64.4% Q4 and 65.3% FY, up from 62.7% and 54.5%.","Adjusted EBITDA Q4 $15.0M (18.3% margin) vs $9.0M (10.8%) YoY; FY $45.1M vs $12.3M.","Delivery systems sold Q4 1,032 (-5% YoY); active install base rose to 36,026 (+3.7%).","CEO cites operational improvements, strong install base, and recurring consumables model."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109023,"accession_number":"0001628280-26-015640","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Beauty Health settles derivative suit over Syndeo launch; adopts governance reforms","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Non-monetary settlement of derivative action in Delaware Chancery; court approval hearing set for May 13, 2026.","Seven governance reforms include Quality Ombudsman, enhanced inventory monitoring, and financial projection oversight.","Plaintiffs' attorneys to seek $737,500 in fees; amount agreed after mediation overseen by Phillips ADR.","Settlement releases all derivative claims against current/former officers/directors; defendants deny wrongdoing.","Reforms must be implemented within 90 days of final approval and remain in effect for at least four years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125477,"accession_number":"0001628280-25-050171","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q3 2025 revenue $70.7M down 10% YoY; Adj EBITDA $8.9M beats guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $70.7M vs $78.8M YoY; net loss improved to $11.0M from $18.3M.","Adjusted EBITDA of $8.9M (12.6% margin) exceeded top end of guidance range.","Delivery systems sold 875 vs 1,118 YoY; consumables net sales $49.8M vs $51.2M.","Active install base grew to 35,409 from 34,162 YoY.","CEO cites disciplined execution; no FY guidance range updated in the release."],"consensus_eps_estimate":-0.0691,"consensus_eps_actual":-0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":218422000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125476,"accession_number":"0001628280-25-048229","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"BeautyHealth appoints Philippe Schaison, former Allergan Aesthetics President, to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Philippe Schaison appointed to Board effective Oct 30, 2025; joins Compensation and Nominating & Corporate Governance Committees.","Schaison is CEO and director of Soltégo, ex-CEO NA of Syneron Candela, and former President of Allergan Aesthetics.","Appointment expands Board to eight directors; Schaison qualifies as independent under Nasdaq rules.","Schaison brings over 20 years leading global aesthetics, biotech, and consumer health businesses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125475,"accession_number":"0001628280-25-045385","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K/A","filed_at":"2025-10-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Beauty Health Company CEO Marla Beck Terminated Without Cause, Enters Separation Agreement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Marla Beck terminated as CEO, President, and director effective September 30, 2025, without cause and with no disagreement on Company matters.","Separation agreement provides 18 months of base salary continuation, prorated 2025 annual bonus, and COBRA premium reimbursement for up to 18 months.","Performance share units with a grant-date value of $1,700,000 vest fully on the separation date.","Beck will serve as a consultant from October 1 through December 31, 2025, receiving $250,000 paid bi-weekly and counting toward 2025 annual incentive plan.","Company will reimburse up to $10,000 in legal fees; Beck signed a general release of all claims."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142217,"accession_number":"0001628280-25-043256","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-09-30T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Beauty Health names Pedro Malha as CEO effective Oct 1; Marla Beck steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Pedro Malha appointed President and CEO effective October 1, 2025; replaces Marla Beck who steps down Sept 30, remains advisor through Dec 31.","Malha previously Worldwide Division President at Abbott Laboratories (2021-2025) and senior roles at Zimmer Biomet and J&J.","Compensation: $800k base salary, $450k one-time cash bonus, initial LTI equity grant of $2.556M (75% RSU, 25% PSU).","Malha also appointed to Board of Directors effective Oct 1.","Beck departure follows transformation; company cites strengthened pipeline and cost structure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142216,"accession_number":"0001683168-25-006690","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-09-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Beauty Health adds foreign subsidiary guarantors to 7.95% convertible notes indenture","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Supplemental Indenture adds foreign subsidiaries as guarantors for the 7.95% Convertible Senior Notes due 2028.","New guarantees are secured on a first-priority basis by substantially all assets of those guarantors.","Indenture also amended to cure certain ambiguities, omissions, defects and inconsistencies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142215,"accession_number":"0001628280-25-038879","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Beauty Health beats Q2, raises FY2025 forecast; revenue $78.2M, adj. EBITDA $13.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $78.2M (down 13.7% YoY but beat expectations); net income $19.7M vs $0.2M.","Adjusted EBITDA surged to $13.9M from $(5.2)M; adjusted gross margin 65.9% (vs 49.4%).","Raised full-year 2025 outlook on strong consumables growth and cost discipline.","Active device install base 35,193 (+5% YoY); consumables 71% of revenue at $55.8M.","Innovation engine delivering: HydraFillic with Pep9 Booster launched successfully."],"consensus_eps_estimate":-0.0539,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":147767000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142214,"accession_number":"0001628280-25-037230","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-08-01T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Beauty Health corrects charter to allow director removal without cause; Fanning named committee chair","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Certificate of Correction filed July 31, 2025, fixes scrivener's error in Amended Certificate; directors may now be removed with or without cause by majority vote.","Stephen Fanning, independent board member, appointed Chairman of Nominating and Corporate Governance Committee effective July 31, 2025.","Fanning also serves on Audit Committee and Nominating and Corporate Governance Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160223,"accession_number":"0001628280-25-031820","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-06-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"The Beauty Health Company annual meeting results: directors elected, auditor ratified, say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders elected all seven director nominees: Marla Beck, Brenton Saunders, Doug Schillinger, Stephen Fanning, Brian Miller, Desiree Gruber, Michelle Kerrick.","Ratification of Deloitte & Touche LLP as independent auditor for 2025 was approved with 98,627,630 votes for, 102,141 against, and 49,794 abstentions.","Advisory vote on named executive officer compensation passed with 67,289,182 votes for, 19,578,688 against, 1,071,787 abstentions, and 10,839,908 broker non-votes.","Approximately 78.40% of outstanding shares were represented at the annual meeting on June 12, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160222,"accession_number":"0001683168-25-004033","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-05-27T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Beauty Health issues $250M 7.95% convertible notes due 2028; conversion price ~$2.86","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$250M principal amount of 7.95% Convertible Senior Secured Notes due Nov 15, 2028 issued on May 27, 2025.","Initial conversion rate: 349.6503 shares per $1,000 principal (conversion price ~$2.86 per share).","Notes are senior secured obligations guaranteed by material domestic wholly-owned subsidiaries.","Notes redeemable at Company's option on/after Sept 1, 2028 subject to liquidity conditions; holders may require repurchase upon fundamental change.","Indenture includes restrictive covenants limiting indebtedness, liens, investments, and restricted payments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160221,"accession_number":"0001683168-25-003922","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-05-21T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Beauty Health exchanges $413.2M of 1.25% notes due 2026 for $250M of 7.95% secured notes due 2028 plus cash","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Exchanges ~$413.2M aggregate principal of existing 1.25% convertible notes due 2026 for $250M new 7.95% convertible senior secured notes due 2028.","Issues ~$143.4M in cash including accrued interest to exchanging holders.","New notes secured, guaranteed by material domestic subsidiaries; conversion price ~$2.86 per share (initial rate 349.6503 shares/$1,000).","Expected close on or about May 27, 2025; extends debt maturity by two years.","CEO cites strengthened financial position and flexibility to invest in long-term growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160220,"accession_number":"0001628280-25-023780","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q1 revenue $69.6M (-14% YoY); adjusted EBITDA $7.3M vs $0.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $69.6M down from $81.4M; delivery systems $20.2M (-43.6%), consumables $49.4M (+8.3%).","Net loss $10.1M vs loss $0.7M; adjusted EBITDA $7.3M (10.4% margin) vs $0.4M.","Gross margin improved to 69.8% from 59.4%; delivery systems sold 862, install base 35,014 (+7.6%).","CEO cites exceeding revenue and adjusted EBITDA guidance; relocating production to U.S. to mitigate tariff risk.","Transitioning China operations to a distributor model; product launches and brand initiatives planned."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":69580000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178519,"accession_number":"0001628280-25-012343","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q4 net sales $83.5M; adjusted EBITDA $9M, exceeds guidance high end","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $83.5M, full year $334.3M; adjusted EBITDA $9.0M (10.8% margin), exceeding guidance.","Consumables net sales rose to $56.7M in Q4; delivery systems sold 1,087 (down from 1,551 YoY).","Active install base grew to 34,735 from 31,446 a year ago, up 10.5%.","Gross margin expanded to 62.7% in Q4 vs. 47.2% in Q4 2023; full year margin 54.5% vs. 39.0%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178518,"accession_number":"0001628280-25-009050","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Beauty Health designates Menezes, Lewis as executive officers; discloses compensation","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ronald Menezes (CRO) and Sheri Lewis (Chief Supply Chain & Ops) designated as Section 16 executive officers on Feb 25, 2025.","Menezes: $450K base salary, $100K sign-on bonus, 60% target annual bonus, $800K RSU award (3-yr vest).","Lewis: $485K base salary, $75K sign-on bonus, 60% target annual bonus, $1.181M RSU + $393.75K PSU (3-yr vest).","Both were appointed earlier (Menezes Oct 2024, Lewis Apr 2024); the designation formalizes executive officer status.","Compensation details filed in offer letters; press releases on appointments (including CMO in Oct 2024) furnished."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195195,"accession_number":"0001628280-24-051683","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-12-17T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"BeautyHealth appoints Stephen J. Fanning to Board; former Hydrafacial Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephen Fanning appointed to BeautyHealth board effective Dec 12, 2024; joins Audit & Nominating committees.","Fanning served as Hydrafacial Chairman from 2016-2020 prior to its IPO; led Solta Medical (Thermage, Fraxel).","Recent roles include CEO of Spectrum Solutions and Z-Medica; previously held senior roles at Johnson & Johnson.","Board now has eight directors; Fanning qualifies as independent under Nasdaq rules.","Compensation follows standard non-employee director package as disclosed in April 2024 proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195194,"accession_number":"0001628280-24-047122","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q3 net sales $78.8M (-19% YoY); adj. EBITDA $8.1M, revenue guidance cut, EBITDA raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $78.8M, down 19.1% YoY; delivery systems sales fell 46% to $27.6M, consumables up 10% to $51.2M.","Net loss narrowed to $18.3M from $73.8M; GAAP gross margin improved to 51.6% from -12.9% YoY.","Adjusted EBITDA $8.1M vs $9.1M; adjusted EBITDA margin 10.2% vs 9.3%.","Full-year net sales guidance lowered; adjusted EBITDA guidance improved citing Q3 profitability.","Centralized manufacturing in Long Beach by year-end, ending China partner relationship; new CRO and CMO hired."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":250799000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195192,"accession_number":"0001628280-24-047098","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K/A","filed_at":"2024-11-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Beauty Health terminates CRO Daniel Watson without cause; $430K severance, RSU acceleration","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chief Revenue Officer Daniel Watson terminated without cause effective Oct 14, 2024; advisory role through Jan 1, 2025.","Receives $430K cash severance over 12 months, plus accelerated vesting of 329,251 RSUs.","Will serve as consultant Jan-Mar 2025 at $40K/month; non-compete through March 2026.","Separation Agreement filed; Watson releases all claims against the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195193,"accession_number":"0001628280-24-042835","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-10-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Beauty Health terminates CRO Daniel Watson without cause, effective Oct 14","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Daniel Watson terminated as Chief Revenue Officer without cause, effective October 14, 2024.","Watson will remain as advisor until no later than December 31, 2024.","Separation agreement pending; amendment to 8-K to be filed within four business days of agreement.","Termination not related to any disagreement on financial reporting, operations, or policies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211458,"accession_number":"0001628280-24-038962","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-08-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Julius Few resigns from Beauty Health board effective immediately","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Julius Few resigned as director on August 26, 2024; also left Nominating and Corporate Governance Committee.","Resignation was not due to any dispute with company, management, or board.","Michael Monahan, CFO, signed the Form 8-K on August 30, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211457,"accession_number":"0001628280-24-036121","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q2 net sales down 23% YoY to $90.6M; revises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $90.6M, down 22.9% YoY; equipment sales fell while consumables grew 6.7%.","Delivery systems sold 1,285 vs 2,822 in Q2 2023; active install base grew to 33,504 (+13%).","Adjusted EBITDA loss $5.2M vs positive $12.4M last year; adjusted gross margin 49.4% vs 64.5%.","Operating expenses improved nearly $18M YoY; company cites cost efficiency.","Full year 2024 guidance revised downward, citing slower device recovery and macro pressures."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":171997000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230100,"accession_number":"0001628280-24-027695","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Beauty Health stockholders approve board declassification and eliminate supermajority vote","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board declassification approved, effective 2025 annual meeting; all directors will stand for annual election.","Supermajority amendment passed: future charter amendments require only majority vote (down from 66 2/3%).","Stockholders ratified Deloitte & Touche as auditor for FY 2024 with 108.8M votes for, 63K against.","Advisory vote on named executive officer compensation passed with 96.8M for, 2.4M against.","Three Class III directors re-elected: Marla Beck, Brenton Saunders, Doug Schillinger (each >93M votes for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230099,"accession_number":"0001628280-24-022209","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q1 net sales $81.4M, -5.7% YoY; net loss narrows to $0.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Delivery systems net sales $35.8M (down 21% from $45.4M); consumables $45.6M (up from $40.9M).","Net loss improved to ($0.7M) from ($20.3M); adjusted EBITDA $0.4M vs ($0.5M) YoY.","Repurchased $192.3M of convertible notes through May 8.","Gross margin 59.4% (adjusted 63.4%) vs 62.7% (adjusted 70.0%) a year ago.","Active install base 32,530, up from 27,406; 1,417 delivery systems sold vs 1,774."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":81403000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230096,"accession_number":"0001628280-24-019980","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K/A","filed_at":"2024-05-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Beauty Health files separation agreement with departing COO Brad Hauser; $400K severance, 12-month non-compete","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Brad Hauser mutually terminated without cause effective April 9, 2024; remains in advisory role through June 30, 2024.","Separation agreement provides $400,000 cash severance paid bi-weekly over 12 months post-separation, plus $85,000 retention award on June 1, 2024.","COBRA employer premium portion reimbursed for 12-month post-separation period if Employee timely elects coverage.","Non-compete prohibits Hauser from working with competitors in microdermabrasion/hydrodermabrasion machine market for 12 months; includes specific named entities (redacted).","Hauser agrees to provide transition services to Chief Supply Chain and Operations Officer and cooperate in litigation; capped at 25 free hours, then $300/hour."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230098,"accession_number":"0001628280-24-015457","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Beauty Health COO Brad Hauser departs effective April 9; advisory role through June 30","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brad Hauser mutually agreed to terminate COO role effective April 9, 2024; remains as advisor until June 30.","Separation is not due to any disagreement with the Company on financial reporting, operations, or policies.","Company will file a separate 8-K for the definitive separation agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230097,"accession_number":"0001628280-24-015295","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-04-08T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Beauty Health discloses SEC subpoena; finalizes CEO Marla Beck employment terms","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SEC's Enforcement Division issued subpoena in formal investigation; company cooperating, cannot predict scope or outcome.","Marla Beck named President and CEO effective April 8; receives $1M base salary, $500k special bonus, $6M equity award.","Annual bonus targeted at 100% of base; equity includes RSUs and PSUs with performance vesting tied to stock price milestones.","Executive severance plan amended: removes tiers for non-exec officers hired after March 2024, adds tenure-based cash severance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248535,"accession_number":"0001628280-24-010538","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q4 net sales $96.8M (-1.3% YoY); full year net loss $100.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year net sales $398.0M, up 8.8% YoY; Q4 net sales $96.8M, down 1.3% YoY.","Full year net loss $100.1M (vs $44.2M income in 2022); Q4 net loss $9.4M (vs $6.5M income).","Full year adjusted EBITDA $24.3M (6.1% margin) vs $46.1M (12.6% margin) in 2022.","Total delivery systems sold in Q4 1,551 vs 2,067 YoY; active install base grew 24% to 31,446.","Adjusted gross margin fell to 54.6% in Q4 from 73.6% in prior year; full year 62.8% vs 72.6%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248534,"accession_number":"0001628280-24-010531","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2024-03-12T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Beauty Health appoints Marla Beck as permanent CEO; she had been interim since Nov 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Marla Beck named permanent President and CEO effective March 12, 2024.","She served as Interim CEO since November 20, 2023 and will remain on the Board.","Board conducted extensive search and unanimously approved Beck's appointment.","Beck founded Bluemercury, leading it to a strategic sale to Macy's in 2015."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266042,"accession_number":"0001628280-23-041578","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K/A","filed_at":"2023-12-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Beauty Health finalizes separation with former CEO Stanleick; 58,536 shares vested, 18-month non-compete","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Andrew Stanleick terminated without cause effective Nov 19, 2023; signed Separation Letter on Dec 8, 2023.","Severance includes 18 months base salary, prorated target bonus, COBRA reimbursements, and outplacement up to $15,000.","Retention award of 58,536 shares of Class A common stock fully vested within 15 days of signing release.","18-month non-competition covenant barring work with microdermabrasion/hydrodermabrasion machine manufacturers.","Mutual non-disparagement agreed; Stanleick remains bound by existing confidentiality obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266046,"accession_number":"0001628280-23-040443","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-12-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Beauty Health grants $1.54M retention bonuses to CFO, COO, CRO amid transformation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cash retention awards: CFO Monahan $85,500, COO Hauser $85,500, CRO Watson $88,200; payable in lump sum if employed through June 1, 2024.","RSU retention awards: Monahan 176,711 RSUs ($445,313), Hauser 176,711 ($445,313), Watson 156,250 ($393,750) at $2.52/share.","Vesting: 50% on Dec 1, 2024, 50% on June 1, 2025, subject to continued employment; accelerated vesting upon death/disability or specified CIC-related termination.","Retention bonuses aim to keep executives during business transformation to reduce operating costs and streamline operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266045,"accession_number":"0001628280-23-039265","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-11-16T23:59:59+00:00","items":["2.05"],"status":"ready","headline":"Beauty Health cuts 10% of workforce (95 employees); expects $5.1M Q4 charge","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Workforce reduction of 95 employees (63 US, 32 international), reducing headcount to 893.","Estimated Q4 2023 charges of $5.1 million for notice pay, severance, and related costs.","Expects annualized savings of ~$17M from workforce reduction and ≥$3M from non-headcount cuts.","Phase 1 of cost savings plan expected to be substantially complete by March 31, 2024.","Cash and equivalents of $559.4M at Sept 30, 2023; company believes sufficient for 12+ months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266044,"accession_number":"0001628280-23-038610","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth reports Q3 net loss of $73.8M, revises FY2023 guidance lower","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $97.4M (+10% YoY) but gross loss of $12.6M vs $61.4M profit a year ago; $63.1M restructuring charge for Syndeo device upgrades.","Net loss $73.8M vs $0.1M loss prior year; adjusted EBITDA $9.1M (9.3% margin) down from $16.3M (18.4% margin).","Revised FY2023 guidance: net sales $385-400M, adjusted EBITDA margin 5-6%; suspends long-term 2025 outlook.","U.S. revenue weaker than expected; APAC and EMEA delivered double-digit growth; total delivery systems sold 2,140 vs 1,860."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":301170000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266043,"accession_number":"0001628280-23-038598","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Beauty Health CEO Andrew Stanleick departs; director Marla Beck named interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Stanleick steps down as CEO and board member effective Nov 19, 2023; will advise through Dec 31, 2023.","Director Marla Beck appointed interim CEO from Nov 20, 2023, for a 6-month term; resigns from audit committee.","Beck co-founded Bluemercury; led it as CEO for 22 years including post-acquisition by Macy's.","Interim CEO compensation: $200K monthly base (min. 4 months), $500K RSUs ratably vesting over term, $400K change-in-control bonus.","Board has initiated a formal search for a permanent CEO; Saunders expresses confidence in strategy and long-term growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283277,"accession_number":"0001628280-23-032118","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-09-13T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"BeautyHealth launches cost-cutting program targeting $35M+ annual savings, $100M buyback","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Phase 1 expected to generate >$20M annualized cost savings in Q1 2024; Phase 2 >$15M in Q2 2024.","Board authorized $100M share repurchase program; funded from existing cash, via Rule 10b5-1 plan in Q3 2023.","Company re-affirms 2025 guidance: $600-$700M net sales, up to 500 bps gross margin expansion vs FY2021, 25-30% EBITDA margin.","Cost reductions from streamlining go-to-market, process automation, and manufacturing efficiencies; no large M&A anticipated.","Update on transformation program expected during Q3 2023 earnings call in November 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283276,"accession_number":"0001628280-23-028406","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"BeautyHealth Q2 net sales $117.5M (+13% YoY); net income $3.4M; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $117.5M (+13% YoY); net income $3.4M; adjusted EBITDA margin 15.1%.","Reaffirms 2023 net sales and 2025 guidance; refines 2023 adj. EBITDA margin to 18%-19%.","Consumables net sales +34% YoY; delivery systems +1% (or +30% ex trade-ups).","APAC net sales +143% YoY (China +265%); partner LaserAway for Syndeo at 125+ locations.","FDA clearance for SkinStylus for facial acne scarring; AWS collaboration for generative AI."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":203757000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283275,"accession_number":"0001628280-23-028404","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Beauty Health names Michael Monahan CFO, replacing Liyuan Woo effective Aug 10, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Monahan appointed CFO effective August 10, 2023; Liyuan Woo steps down, stays as advisor until September 1.","Monahan receives $475k base salary, $100k one-time cash bonus, and $2.5M RSUs vesting over three years.","Woo gets severance: 18 months base salary, prorated 2023 target bonus, extended option exercise for 372k shares.","Monahan brings ~15 years CFO experience, most recently at Casper Sleep, previously Nutrisystem."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302697,"accession_number":"0001628280-23-022890","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-06-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Beauty Health shareholders pass all three proposals at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All three Class II director nominees (Capellas, Few, Miller) re-elected to three-year terms.","Deloitte & Touche ratified as independent auditor for FY 2023 with over 99.6% of votes cast.","Advisory say-on-pay resolution approved with over 99.6% of votes cast.","Over 91.9% of outstanding shares represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302696,"accession_number":"0001628280-23-017025","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-05-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"BeautyHealth Q1 net sales $86.3M (+14% YoY), net loss $22.3M, raises FY23 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $86.3M (+14% YoY); consumables +21% YoY led by Americas +34% and EMEA +35% ex-Russia.","Net loss $22.3M vs net income $31.5M in prior year; adjusted EBITDA loss $0.5M vs +$1.2M.","GAAP gross margin 62.7% (down from 67.5%); adjusted gross margin 70.0% (down from 71.3%).","Company raises FY2023 net sales guidance and reaffirms EBITDA margin and 2025 long-term targets.","Syndeo international launch planned for Q2 2023; China COVID shutdowns affected Jan-Feb but rebound in March."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":86278000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302695,"accession_number":"0001818093-23-000014","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-04-19T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"BeautyHealth promotes Brad Hauser to COO with $1.4M in equity grants","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brad Hauser appointed COO effective April 19, 2023; previously Chief Product Officer since Jan 2023.","Base salary of $475k; target annual bonus at 60% of base under AIP.","Receives one-time RSU grant of $1.05M (3-year vest) and PSU grant of $350k (3-year performance period).","Eligible for Executive Severance Plan: 12 months base salary + prorated bonus + COBRA upon qualifying termination.","Hauser will oversee full product lifecycle including R&D, operations, marketing as part of multi-brand strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302694,"accession_number":"0001818093-23-000013","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-04-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Beauty Health amends executive severance plan; extends CIC protection to 12 months, boosts Tier 2 benefits","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CIC Protection Period extended from 9 to 12 months; cash severance now paid in lump sum after a qualified termination.","Tier 2 participants receive 9 months base salary (up from 6) and 9 months health benefits (up from 6).","Tier 2 target bonus payout increased to 100% (previously 50%) for CIC-related terminations.","Severance payments no longer suspended if executive takes new job during payout period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322338,"accession_number":"0001818093-23-000008","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-03-02T23:59:59+00:00","items":["3.02","8.01"],"status":"ready","headline":"Beauty Health closes acquisition of Esthetic Medical Inc. for $11.8M cash plus stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all outstanding shares of EMI for $11.79M cash and 109,625 shares of Class A common stock.","Seller eligible for up to $3.2M additional earnout: $1.9M in royalty payments and $1.3M upon FDA facial indication clearance.","EE LLC transferred microneedling IP and inventory assets (SkinStylus, SteriLock) to EMI as part of the deal.","Buyer entered into consulting agreements with Dr. Lawrence Groop and Kristin Groop for transition services."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322337,"accession_number":"0001818093-23-000004","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"BeautyHealth reports FY2022 net sales $365.9M (+41% YoY); guides FY2023 $450-470M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year net sales $365.9M (+41% YoY); Q4 net sales $98.1M (+26% YoY).","Full year net income $44.4M vs net loss $375.1M in 2021; adjusted EBITDA $47.7M (+46% YoY).","Guides FY2023 net sales $450-470M; affirms 18-20% adjusted EBITDA margin target.","Confirms long-range 2025 guidance: net sales $600-700M, 25-30% adjusted EBITDA margin.","Syndeo launch and China expansion key drivers; 8,492 delivery systems sold in 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":365876000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322336,"accession_number":"0001818093-23-000003","cik":1818093,"company_name":"SkinHealth Systems Inc.","ticker":"SKIN","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"BeautyHealth acquires SkinStylus microneedling device for $16.3M in cash and stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration of $16.3M: $14.99M cash (incl. up to $3.2M contingent payments) and $1.31M in SKIN stock.","Acquisition of SkinStylus, an FDA-cleared class II microneedling device, complementary to Hydrafacial.","Contingent payments tied to cartridge royalties ($1.9M) and FDA facial indication clearance ($1.3M) within 120 days.","Deal expected to contribute upside in 2024 and beyond; microneedling market projected to reach $1B by 2030.","Seller (Dr. Lawrence Groop) to provide consulting services post-close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":102960745.34615876,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-02-28T23:59:59+00:00|322336"}